MENU

EOCN Eocene Ltd. Forecast, Technical & Fundamental Analysis

Eocene Ltd is a GI-focused medtech and biopharmaceutical company focused on advancing solutions across gastrointestinal disease management, GI oncology and related therapeutic areas... Show more

EOCN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
EOCN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

EOCN is expected to report earnings to rise 9.09% to -311 cents per share on November 25

Eocene Ltd. EOCN Stock Earnings Reports
Q3'26
Est.
$-3.12
Q2'26
Beat
by $0.26
The last earnings report on July 30 showed earnings per share of -285 cents, beating the estimate of -311 cents. With 1.83K shares outstanding, the current market capitalization sits at 3.87M.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Other
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELAB4.820.20
+4.33%
PMGC Holdings Inc
NVRI21.51-0.04
-0.19%
Enviri Corporation
TSN52.55-0.61
-1.15%
Tyson Foods
JATT12.05-0.20
-1.63%
Jatt II Acquisition Corp
AAUC21.10-0.49
-2.27%
Allied Gold Corp

EOCN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EOCN has been closely correlated with XBIO. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if EOCN jumps, then XBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EOCN
1D Price
Change %
EOCN100%
-0.82%
XBIO - EOCN
88%
Closely correlated
-1.39%
ELOX - EOCN
57%
Loosely correlated
+11.96%
NVAX - EOCN
34%
Loosely correlated
-3.75%
CMMB - EOCN
30%
Poorly correlated
+0.82%
RXRX - EOCN
29%
Poorly correlated
-4.99%
More
Eocene (EOCN) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com